SKIN
The Beauty Health Co.
NASDAQ · Consumer Defensive · Household & Personal Products · US
$11.16
+5.78%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 290.0M | 300.8M | 334.3M | 398.0M | 365.9M |
| Cost of Revenue | 97.6M | 104.4M | 152.0M | 242.9M | 117.1M |
| Gross Profit | 192.4M | 196.4M | 182.3M | 155.1M | 248.8M |
| Operating Expenses | |||||
| R&D Expense | 5.9M | 5.6M | 6.3M | 10.1M | 8.4M |
| SG&A Expense | 190.8M | 211.5M | 243.8M | 275.9M | 266.2M |
| General & Admin Expense | 102.2M | 117.9M | 125.5M | 131.4M | 106.1M |
| Selling & Marketing Expense | 88.7M | 93.6M | 118.3M | 144.5M | 160.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 196.7M | 217.2M | 250.1M | 286.0M | 274.6M |
| Cost and Expenses | 294.3M | 321.6M | 402.1M | 528.9M | 391.7M |
| Operating Income (EBIT) | (4.3M) | (20.8M) | (67.8M) | (130.9M) | (25.8M) |
| Non-Operating | |||||
| Interest Income | 5.5M | 9.0M | 16.6M | 23.2M | 9.2M |
| Interest Expense | 25.3M | 19.3M | 10.4M | 13.6M | 13.4M |
| Net Interest Income | (19.8M) | (10.4M) | 6.2M | 9.5M | (4.2M) |
| Other Non-Op Income/Expense | (19.4M) | 14.9M | 38.2M | 29.0M | 71.2M |
| Non-Operating Income (excl Interest) | (5.9M) | (34.2M) | (48.6M) | (42.7M) | (84.6M) |
| EBT (Pre-Tax Income) | (23.7M) | (5.9M) | (29.6M) | (101.9M) | 45.3M |
| Income Tax Expense | 4.7M | 3.6M | (452.0K) | (1.8M) | 1.1M |
| Bottom Line | |||||
| Net Income | (28.4M) | (9.5M) | (29.1M) | (100.1M) | 44.2M |
| Earnings from Cont. Ops | (28.4M) | (9.5M) | (29.1M) | (100.1M) | 44.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (27.9M) | (22.1M) | (51.8M) | (100.1M) | (34.1M) |
| Per Share | |||||
| Basic EPS | ($4.51) | ($1.60) | ($4.60) | ($15.20) | $6.00 |
| Diluted EPS | ($4.47) | ($3.20) | ($7.20) | ($15.20) | ($4.60) |
| Revenue Per Share | $44.76 | $47.60 | $53.99 | $60.45 | $49.59 |
| Shares | |||||
| Basic Shares Outstanding | 6.5M | 6.3M | 6.2M | 6.6M | 7.4M |
| Diluted Shares Outstanding | 6.5M | 6.8M | 7.1M | 6.6M | 7.4M |
| Profitability Metrics | |||||
| EBITDA | 26.0M | 38.7M | 14.5M | (53.6M) | 81.6M |
| D&A | 24.4M | 25.3M | 33.7M | 34.7M | 22.9M |
| EBIT | 1.6M | 13.4M | (19.1M) | (88.2M) | 58.7M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026